PBS Biotech has filed a notice of an exempt offering of securities to raise $34,706,776.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, PBS Biotech is raising $34,706,776.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Brian Lee played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About PBS Biotech
PBS Biotech aims to be the leading provider of innovative, single-use bioreactor systems specifically designed to address the unique challenges of cultivating shear sensitive cell types for cell therapy development. Our offering includes scalable, cost-effective disposable solutions designed to take you from benchtop R&D to large-scale cGMP manufacturing, and expert process development services to help solve cell culture challenges and accelerate your path to commercialization.
To learn more about PBS Biotech, visit http://www.pbsbiotech.com/
Contact:
Brian Lee, Chief Executive Officer
805-795-0399
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.